Neutral impactCompany

Capacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD Maulik Patel

BusinessLine 4 hrs ago·27 Sept 2026, 10:38 am

The company expects to reach ₹2,900 crore in revenue this fiscal year following revenue of ₹2,500–2,530 crore in 2026

Key takeaways

  • Category: Company.

Why it matters

A routine update. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at BusinessLine.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.